Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine for anxiety in COPD
ACTRN12613000458730Phase 4Not yet recruiting
- Sponsor
- Department of Respiratory Medicine, The Queen Elizabeth Hospital
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder comparing Paroxetine with Placebo (2 arms). Primary endpoint: Anxiety. Planned start May 2013; status: not yet recruiting.
02
Drugs
paroxetine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ACTRN12613000458730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000458730.